Industry

DUBLIN–(BUSINESS WIRE)–The “Non-Alcoholic Steatohepatitis Treatment Market, by Drug, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. This report provides an in-depth analysis of the global nonalcoholic steatohepatitis treatment market, and provides market size (US$ Million) and compound annual growth rate … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Logistics Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical Logistics Market is projected to reach USD 85.11 billion by 2027 from USD 63.60 billion in 2021, at a CAGR 4.97% during the forecast period. In this report, the years 2019 and 2020 … [Read more…]

LITTLE RIVER, S.C.–(BUSINESS WIRE)–$PCTL #EOR—PCT LTD (OTC Pink: PCTL) August 19, 2022. PCT LTD., operating through its wholly owned operating subsidiary Paradigm Convergence Technologies, Inc (PCT) today announced that it is in the process of segregating their Healthcare and Oil & Gas technologies into separate wholly owned subsidiaries to capitalize on marketing opportunities. The PCT … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Mechanical Circulatory Support Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information about the Mechanical Circulatory Support Devices pipeline products with comparative analysis of the products at various stages of development and information … [Read more…]

HAYWARD, Calif.–(BUSINESS WIRE)–#antibodies—Aarvik Therapeutics announced the recent publication by Sachdev Sidhu, Ph.D., Co-founder of Aarvik Therapeutics, and his colleagues of a study validating the novel tetravalent antibody platform that forms a core component of innovation at Aarvik. This study by Miersch et al. uses modular design principles to combine neutralizing antibodies against two independent epitopes … [Read more…]

CRANBURY, N.J. & SHANGHAI–(BUSINESS WIRE)–Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces that the China National Medical Products Administration (NMPA) has cleared the company’s investigational new drug application (IND) for AC0176 for the treatment of patients with metastatic Castration Resistant Prostate Cancer (mCRPC). AC0176 is an orally … [Read more…]

CLEVELAND–(BUSINESS WIRE)–Members of some Medical Mutual groups have been impacted by a third-party vendor data incident. OneTouchPoint (OTP) provides printing and mailing services for Medical Mutual’s Quit Logix/QuitLine tobacco cessation program, administered by National Jewish Health. Medical Mutual learned on July 26, 2022, that member information may have been impacted by a ransomware attack experienced … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Dermatology Devices Market Research Report by Product (Diagnostic Devices and Treatment Devices), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Dermatology Devices Market size was estimated at USD 14.93 billion in 2021, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Decompensated Cirrhosis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Decompensated Cirrhosis- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Decompensated Cirrhosis, historical and forecasted epidemiology as well as the Decompensated Cirrhosis market trends in the United States, EU5 (Germany, … [Read more…]

PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022. Ms. Sabella will be working in a strategic advisory role for early-stage biotechnology companies. “We are grateful for Lauren’s thirteen years of contributions as a member of Acorda’s executive leadership … [Read more…]